As a child nutritionist and a mom of twins, I've noticed a troubling pattern in my practice: eczema cases in young Indian ...
INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...
During the cold winter months, many people notice their skin’s condition worsens. Dry air and indoor heating can exacerbate symptoms of eczema, or atopic dermatitis. This leads to dry, cracked ...
With shares down more than 40% since November, the risk-reward for Nektar Therapeutics has shifted ahead of pivotal clinical ...
Topical pumecitinib 3% gel shows strong efficacy and good tolerability in mild-to-moderate atopic dermatitis. Explore the ...
Amlitelimab is effective at improving moderate to severe AD across all body regions, including the difficult-to-treat head and neck region.
Among patients with moderate to severe atopic dermatitis, atopic comorbidities did not change the benefits seen with lebrikizumab, according to data published in Annals of Allergy, Asthma & Immunology ...
To help you find the best eczema-friendly skin care products, I tapped several dermatologists for their insights and product recommendations.
Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of ...
TRex Bio banked a Series B extension to advance its atopic dermatitis program, which is competing in a crowded field.
Topline data were announced from two phase 3 trials evaluating amlitelimab for the treatment of moderate to severe atopic dermatitis.
Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results